Continuing controversies in the management of thyroid nodules

Annals of Internal Medicine

Volumn 142, Issue 11, 2005, Pages 926-931

  Castro, M Regina ^a,b   Gharib, Hossein ^a  

^a Mayo Clinic College of Medicine and Science   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; GALECTIN 3; LEVOTHYROXINE; THYROTROPIN; THYROXINE;

ASPIRATION BIOPSY; BENIGN TUMOR; BONE MARROW CELL; CYTOLOGY; EARLY DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; NEEDLE BIOPSY; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; THYROID MEDULLARY CARCINOMA; THYROID NODULE; BLOOD; ECHOGRAPHY; METHODOLOGY; PALPATION;

BIOPSY, FINE-NEEDLE; CALCITONIN; HUMANS; PALPATION; THYROID NODULE; THYROXINE;

EID: 20344406246     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-142-11-200506070-00011     Document Type: Review

References (79)

1. Vander JB, Gaston EA, Dawber TR. The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med. 1968;69:537-40. [PMID: 5673172]
2. Ezzat S, Sarti DA, Cain DR, Braunstein GD. Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med. 1994;154:1838-40. [PMID: 8053752]
3. Mortensen JD, Woolner LB, Bennett WA. Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab. 1955;15:1270-80. [PMID: 13263417]
4. Reading CC, Charboneau JW, James EM, Karsell PR, Purnell DC, Grant CS, et al. High-resolution parathyroid sonography. AJR Am J Roentgenol. 1982; 139:539-46. [PMID: 6981321]
5. Carroll BA. Asymptomatic thyroid nodules: incidental sonographic detection. AJR Am J Roentgenol. 1982;138:499-501. [PMID: 6978000]
6. Werk EE Jr, Vernon BM, Gonzalez JJ, Ungaro PC, McCoy RC. Cancer in thyroid nodules. A community hospital survey. Arch Intern Med. 1984;144: 474-6. [PMID: 6703815]
7. Pepper GM, Zwickler D, Rosen Y. Fine-needle aspiration biopsy of the thyroid nodule. Results of a start-up project in a general teaching hospital setting. Arch Intern Med. 1989;149:594-6. [PMID: 2919935]
8. Asp AA, Georgitis W, Waldron EJ, Sims JE, Kidd GS 2nd. Fine needle aspiration of the thyroid. Use in an average health care facility. Am J Med. 1987;83:489-93. [PMID: 3661585]
9. Hamburger JI. Consistency of sequential needle biopsy findings for thyroid nodules. Management implications. Arch Intetn Med. 1987;147:97-9. [PMID: 3800535]
10. Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med. 1993;118:282-9. [PMID: 8420446]
11. Carmeci C, Jeffrey RB, McDougall IR, Nowels KW, Weigel RJ. Ultrasound-guided fine-needle aspiration biopsy of thyroid masses. Thyroid. 1998;8: 283-9. [PMID: 9588492]
12. Danese D, Sciacchitano S, Farsetti A, Andreoli M, Pontecorvi A. Diagnostic accuracy of conventional versus sonography-guided fine-needle aspiration biopsy of thyroid nodules. Thyroid. 1998;8:15-21. [PMID: 9492148]
13. Goellner JR, Gharib H, Grant CS, Johnson DA. Fine needle aspiration cytology of the thyroid, 1980 to 1986. Acta Cytol. 1987;31:587-90. [PMID: 3673463]
14. Hamburger JI, Husain M. Semiquantitative criteria for fine-needle biopsy diagnosis: reduced false-negative diagnoses. Diagn Cytopathol. 1988;4:14-7. [PMID: 3378485]
15. MacDonald L, Yazdi HM. Nondiagnostic fine needle aspiration biopsy of the thyroid gland: a diagnostic dilemma. Acta Cytol. 1996;40:423-8. [PMID: 8669173]
16. Hamburger JI, Husain M, Nishiyama R, Nunez C, Solomon D. Increasing the accuracy of fine-needle biopsy for thyroid nodules. Arch Pathol Lab Med. 1989;113:1035-41. [PMID: 2774855]
17. Takashima S, Fukuda H, Kobayashi T. Thyroid nodules: clinical effect of ultrasound-guided fine-needle aspiration biopsy. J Clin Ultrasound. 1994; 22:535-42. [PMID: 7806661]
18. Baskin HJ. Ultrasound-guided fine-needle aspiration biopsy of thyroid nodules and multinodular goiters. Endocr Pract. 2004;10:242-5. [PMID: 15310533]
19. Papini E, Guglielmi R, Bianchini A, Crescenzi A, Taccogna S, Nanti F, et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab. 2002;87:1941-6. [PMID: 11994321]
20. Hamburger JI, Hamburger SW. Fine needle biopsy of thyroid nodules: avoiding the pitfalls. N Y State J Med. 1986;86:241-9. [PMID: 3520410]
21. Gharib H, Goellner JR, Zinsmeister AR, Grant CS, Van Heerden JA. Fine-needle aspiration biopsy of the thyroid. The problem of suspicious cytologic findings. Ann Intern Med. 1984;101:25-8. [PMID: 6547282]
22. Ridgway EC. Clinical review 30: clinician's evaluation of a solitary thyroid nodule. J Clin Endocrinol Metab. 1992;74:231-5. [PMID: 1730801]
23. Greaves TS, Olvera M, Florentine BD, Raza AS, Cobb CJ, Tsao-Wei DD, et al. Follicular lesions of thyroid: a 5-year fine-needle aspiration experience. Cancer. 2000;90:335-41. [PMID: 11156516]
24. Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med. 1993;328:553-9. [PMID: 8426623]
25. Burch HB. Evaluation and management of the solid thyroid nodule. Endocrinol Metab Clin North Am. 1995;24:663-710. [PMID: 8608777]
26. Tuttle RM, Lemar H, Burch HB. Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid. 1998;8:377-83. [PMID: 9623727]
27. Raber W, Kaserer K, Niederle B, Vierhapper H. Risk factors for malignancy of thyroid nodules initially identified as follicular neoplasia by fine-needle aspiration: results of a prospective study of one hundred twenty patients. Thyroid. 2000;10:709-12. [PMID: 11014317]
28. Schlinkert RT, van Heerden JA, Goellner JR, Gharib H, Smith SL, Rosales RF, et al. Factors that predict malignant thyroid lesions when fine-needle aspiration is "suspicious for follicular neoplasm". Mayo Clin Proc. 1997;72:913-6. [PMID: 9379692]
29. Cersosimo E, Gharib H, Suman VJ, Goellner JR. "Suspicious" thyroid cytologic findings: outcome in patients without immediate surgical treatment. Mayo Clin Proc. 1993;68:343-8. [PMID: 8455392]
30. Raphael SJ. The meanings of markers: ancillary techniques in diagnosis of thyroid neoplasia. Endocr Pathol. 2002;13:301-11. [PMID: 12665648]
31. Miettinen M, Kärkkäinen P. Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours. Preferential reactivity with malignant tumours. Virchows Arch. 1996;429:213-9. [PMID: 8972756]
32. Xu XC, el-Naggar AK, Lotan R. Differential expression of galectin-1 and galecrin-3 in thyroid rumors. Potential diagnostic implications. Am J Pathol. 1995;147:815-22. [PMID: 7677193]
33. Gasbarri A, Martegani MP, Del Prete F, Lucante T, Natali PG, Bartolazzi A. Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules. J Clin Oncol. 1999;17:3494-502. [PMID: 10550147]
34. Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucarne T, Khan A, et al. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet. 2001;357:1644-50. [PMID: 11425367]
35. Woestyn J, Afschrift M, Schelstraete K, Vermeiden A. Demonstration of nodules in the normal thyroid by echography. Br J Radiol. 1985;58:1179-82. [PMID: 3916164]
36. Bruneton JN, Balu-Maestro C, Marcy PY, Melia P, Mourou MY. Very high frequency (13 MHz) ultrasonographic examination of the normal neck: detection of normal lymph nodes and thyroid nodules. J Ultrasound Med. 1994; 13:87-90. [PMID: 7932966]
37. Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med. 1997;126:226-31. [PMID: 9027275]
38. Chow SM, Law SC, Au SK, Mang O, Yau S, Yuen KT, Lau WH. Changes in clinical presentation, management and outcome in 1348 patients with differentiated thyroid carcinoma: experience in a single institute in Hong Kong, 1960-2000. Clin Oncol (R Coll Radiol). 2003;15:329-36. [PMID: 14524486]
39. Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study. Cancer. 1985;56:531-8. [PMID: 2408737]
40. Feldman AR, Kessler L, Myers MH, Naughton MD. The prevalence of cancet. Estimates based on the Connecticut Tumor Registry. N Engl J Med. 1986;315:1394-7. [PMID: 3773965]
41. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004;54:8-29. [PMID: 14974761]
42. Ito Y, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid. 2003;13:381-7. [PMID: 12804106]
43. Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, Mimura T, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg. 2003;237:399-407. [PMID: 12616125]
44. Farkas EA, King TA, Bolton JS, Fuhrman GM. A comparison of total thyroidectomy and lobectomy in the treatment of dominant thyroid nodules. Am Surg. 2002;68:678-82; discussion 682-3. [PMID: 12206601]
45. Baudin E, Travagli JP, Ropers J, Mancusi F, Bruno-Bossio G, Caillou B, et al. Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer. 1998;83:553-9. [PMID: 9690549]
46. Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH. Papillary microcarcinoma of the thyroid-prognostic significance of lymph node metastasis and multifocality. Cancer. 2003;98:31-40. [PMID: 12833452]
47. Pellegriti G, Scollo C, Lumera G, Regalbuto C, Vigneri R, Belfiore A. Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab. 2004;89:3713-20. [PMID: 15292295]
48. Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery. 1992;112:1139-46; discussion 1146-7. [PMID: 1455316]
49. Hay ID, McConahey WM, Goellner JR. Managing patients with papillary thyroid carcinoma: insights gained from the Mayo Clinic's experience of treating 2,512 consecutive patients during 1940 through 2000. Trans Am Clin Climatol Assoc. 2002;113:241-60. [PMID: 12053713]
50. Noguchi S, Yamashita H, Murakami N, Nakayama I, Toda M, Kawamoto H. Small carcinomas of the thyroid. A long-term follow-up of 867 patients. Arch Surg. 1996;131:187-91. [PMID: 8611077]
51. Kim ES, Kim TY, Koh JM, Kim YI, Hong SJ, Kim WB, et al. Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation. Clin Endocrinol (Oxf). 2004;61:145-8. [PMID: 15212657]
52. Giles Y, Boztepe H, Terzioglu T, Tezelman S. The advantage of total thyroidectomy to avoid reoperation for incidental thyroid cancer in multinodular goiter. Arch Surg. 2004;139:179-82. [PMID: 14769577]
53. Wells SA Jr, Baylin SB, Leight GS, Dale JK, Dilley WG, Farndon JR. The importance of early diagnosis in patients with hereditary medullary thyroid carcinoma. Ann Surg. 1982;195:595-9. [PMID: 7073356]
54. Pacini F, Fontanelli M, Fugazzola L, Elisei R, Romei C, Di Coscio G, et al. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab. 1994;78:826-9. [PMID: 8157706]
55. Hahm JR, Lee MS, Min YK, Lee MK, Kim KW, Nam SJ, et al. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases. Thyroid. 2001;11:73-80. [PMID: 11272100]
56. Rieu M, Lame MC, Richard A, Lissak B, Sambort B, Vuong-Ngoc P, et al. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules. Clin Endocrinol (Oxf). 1995;42:453-60. [PMID: 7621562]
57. Vierhapper H, Raber W, Bieglmayer C, Kaserer K, Weinhäusl A, Niederle B. Routine measurement of plasma calcitonin in nodular thyroid diseases. J Clin Endocrinol Metab. 1997;82:1589-93. [PMID: 9141554]
58. Ozgen AG, Hamulu F, Bayraktar F, Yilmaz C, Tüzün M, Yetkin E, et al. Evaluation of routine basal serum calcitonin measurement for early diagnosis of medullary thyroid carcinoma in seven hundred seventy-three patients with nodular goiter. Thyroid. 1999;9:579-82. [PMID; 10411120]
59. Sheppard MC. Should serum calcitonin be measured routinely in all patients with nodular thyroid disease? Clin Endocrinol (Oxf). 1995;42:451-2. [PMID: 7621561]
60. Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L, et al. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab. 2004;89:163-8. [PMID: 14715844]
61. Hodak SP, Burman KD. The calcitonin conundrum-is it time for routine measurement of serum calcitonin in patients with thyroid nodules? [Editorial] J Clin Endocrinol Metab. 2004;89:511-4. [PMID: 14764754]
62. Niccoli P, Wion-Barbot N, Caron P, Henry JF, de Micco C, Saint Andre JP, et al. Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group. J Clin Endocrinol Metab. 1997;82:338-41. [PMID: 9024213]
63. Scheuba C, Kaserer K, Weinhausl A, Pandev R, Kaider A, Passler C, et al. Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests. Surgery. 1999;126:1089-95; discussion 1096. [PMID: 10598192]
64. Karanikas G, Moameni A, Poetzi C, Zettinig G, Kaserer K, Bieglmayer C, et al. Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects. J Clin Endocrinol Metab. 2004;89:515-9. [PMID: 14764755]
65. Milazzo G, La Rosa GL, Catalfamo R, Vigneri R, Belfiore A. Effect of TSH in human thyroid cells: evidence for both mitogenic and antimitogenic effects. J Cell Biochem. 1992;49:231-8. [PMID: 1322918]
66. Maerthaut C, Lefort A, Libert F, Parmentier M, Raspé E, Roger P, et al. Function, proliferation and differentiation of the dog and human thyrocyte. Horm Metab Res Suppl. 1990;23:51-61. [PMID: 2210634]
67. Shimaoka K, Sokal JE. Suppressive therapy of nontoxic goiter. Am J Med. 1974;57:576-83. [PMID: 4432862]
68. Celani MF, Mariani M, Mariani G. On the usefulness of levothyroxine suppressive therapy in the medical treatment of benign solitary, solid or predominantly solid, thyroid nodules. Acta Endocrinol (Copenh). 1990;123:603-8. [PMID: 2284885]
69. Lima N, Knobel M, Cavalière H, Sztejnsznajd C, Tomimori E, Medeiros-Neto G. Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters. Thyroid. 1997;7:691-7. [PMID: 9349571]
70. La Rosa GL, Lupo L, Giufrrida D, Gullo D, Vigneri R, Belfiore A. Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. Ann Intern Med. 1995;122:1-8. [PMID: 7985890]
71. Zelmanovitz F, Genro S, Gross JL. Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses. J Clin Endocrinol Metab. 1998;83:3881-5. [PMID: 9814462]
72. Wémeau JL, Caron P, Schvartz C, Schlienger JL, Orgiazzi J, Cousty C, et al. Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group. J Clin Endocrinol Metab. 2002;87:4928-34. [PMID: 12414852]
73. Gharib H, James EM, Charboneau JW, Naessens JM, Offord ICP, Gorman CA. Suppressive therapy with levothyroxine for solitary thyroid nodules. A double-blind controlled clinical study. N Engl J Med. 1987;317:70-5. [PMID: 3295553]
74. Larijani B, Pajouhi M, Bastanhagh MH, Sadjadi A, Sedighi N, Eshraghian MR. Evaluation of suppressive therapy for cold thyroid nodules with levothyroxine: double-blind placebo-controlled clinical trial. Endocr Pract. 1999;5:251-6. [PMID: 15251662]
75. Csako G, Byrd D, Wesley RA, Sarlis NJ, Skarulis MC, Nieman LK, et al. Assessing the effects of thyroid suppression on benign solitary thyroid nodules. A model for using quantitative research synthesis. Medicine (Baltimore). 2000;79: 9-26. [PMID: 10670406]
76. Castro MR, Caraballo PJ, Morris JC. Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. J Clin Endocrinol Metab. 2002;87:4154-9. [PMID: 12213864]
77. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994;331:1249-52. [PMID: 7935681]
78. Franklyn JA, Betteridge J, Daykin J, Holder R, Gates GD, Parle JV, et al. Long-term thyroxine treatment and bone mineral density. Lancet. 1992;340:9-13. [PMID: 1351654]
79. Faber J, Galløe AM. Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. Eur J Endocrinol. 1994;130:350-6. [PMID: 8162163]